Radiation from the atomic bomb blasts in Hiroshima and Nagasaki, Japan, in 1945 likely rearranged chromosomes in some survivors who later developed papillary thyroid cancer as adults, according to Japanese researchers.

Writing in Cancer Research, the scientists report that subjects who lived close to the blast sites, were comparably young at the time, and developed the cancer quickly once they reached adulthood, were likely to have a chromosomal rearrangement known as RET/PTC that is not very frequent in adults who develop the disease.

Women with depression may be much more likely than men to get relief from a commonly used, inexpensive antidepressant drug called citalopram, available both as a generic drug and under the brand name Celexa, a new national study finds. But many members of both sexes may find that it helps ease their depression symptoms.

The persistence of a gender difference in response to the drug — even after the researchers accounted for many complicating factors — suggests that there's a real biological difference in the way the medication affects women compared with men. The reasons for that difference are still unclear, but further studies are now examining hormonal variations that may play a role.

Researchers from the University of Michigan Depression Center and their colleagues from around the country tested the drug's ability to help depression patients achieve remission, or total relief from their symptoms, in a multi-year study called STAR*D.

Mosquito traps that reek like latrines are so 2007, thanks to a University of California, Davis research team led by chemical ecologist Walter Leal that have discovered a low-cost, easy-to-prepare attractant that lures blood-fed mosquitoes without making humans hold their noses.

The synthetic mixture, containing compounds trimethylamine and nonanal in low doses, is just as enticing to Culex mosquitoes as the current attractants, Leal said, but this one is odorless to humans.

The research could play a key role in surveillance and control programs for Culex species, which transmit such diseases as West Nile virus, encephalitis and lymphatic filariasis.

Andrew Scholey, Ph.D., professor of Behavioral and Brain Sciences, Swinburne University in Melbourne, Australia has led a research study on the effects of chewing gum on stress relief and focus and concentration. The study found that chewing gum helped relieve anxiety, improve alertness and reduce stress among individuals in a laboratory setting.

The study examined whether chewing gum is capable of reducing induced anxiety and/or acute psychological stress while participants performed a battery of 'multi-tasking' activities. The use of chewing gum was associated with higher alertness, reduced anxiety and stress, and improvement in overall performance on multi-tasking activities.

Shedding some genetically induced excess baggage may have helped the tiny Indostomus paradoxus fish thrive in freshwater and outsize its marine ancestors, according to a University of British Columbia study published in Science Express.

Measuring three to 10 centimetres long, stickleback fish originated in the ocean but began populating freshwater lakes and streams following the last ice age. Over the past 20,000 years - a relatively short time span in evolutionary terms - freshwater sticklebacks have lost their bony lateral plates, or "armour," in these new environments.

"Scientists have identified a mutant form of a gene, or allele, that prohibits the growth of armour," says UBC Zoology PhD candidate Rowan Barrett. Found in fewer than one per cent of marine sticklebacks, this allele is very common in freshwater populations.

All drugs used to treat psychosis are linked to an increased risk of stroke, and dementia sufferers are at double the risk, according to a study published on bmj.com today.

Previous research has shown that second generation (atypical) antipsychotic drugs can increase the chances of patients having a stroke. But the risk of stroke associated with first generation (typical) antipsychotics, and whether the risk differs in people with and without dementia, is not known.

Concerns about an increased risk of stroke among people taking atypical antipsychotic drugs were first raised in 2002, particularly in people with dementia. In 2004, the UK's Committee on Safety of Medicines recommended that these drugs should not be used in people with dementia, despite a lack of clear evidence.